AR028498A1 - Reduccion del crecimiento del pelo - Google Patents

Reduccion del crecimiento del pelo

Info

Publication number
AR028498A1
AR028498A1 ARP010100242A ARP010100242A AR028498A1 AR 028498 A1 AR028498 A1 AR 028498A1 AR P010100242 A ARP010100242 A AR P010100242A AR P010100242 A ARP010100242 A AR P010100242A AR 028498 A1 AR028498 A1 AR 028498A1
Authority
AR
Argentina
Prior art keywords
ceramide
hair growth
composition
compound
increases
Prior art date
Application number
ARP010100242A
Other languages
English (en)
Original Assignee
Gillette Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gillette Co filed Critical Gillette Co
Publication of AR028498A1 publication Critical patent/AR028498A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se ha empleado diversos procedimientos para eliminar el vello no deseado, entre los que se incluyen: el rasurado, la electrolisis, las cremas o lociones depilatorias, la depilacion con cera, la depilacion con pinza y los antiandrogenos terapéuticos. Estos procedimientos convencionales normalmente tienen ciertas desventajas asociadas. Se propone la reduccion en el crecimiento del pelo no deseado en los mamíferos (incluyendo los humanos) en particular, el crecimiento del pelo, estimulado por androgenos mediante el aumento de los niveles de ceramida celulares. Un método destinado a reducir el crecimiento del pelo en un mamífero, el cual comprende: seleccionar una superficie de la piel, en la que se desea reducir el crecimiento del pelo y aplicar sobre dicha superficie de la piel, una composicion dermatologicamente aceptable, la cual comprende un compuesto que aumenta los niveles de ceramida celulares, en una cantidad efectiva para reducir el crecimiento del pelo. El nuevo uso de un compuesto que es: ( 1) un inhibidor de la sintasa de la glucosilceramida; (2) un inhibidor de la ceramidasa: (3) ceramida; (4) un análogo de la ceramida; y/o (5) un inductor de la esfingomielinasa, para reducir el crecimiento del pelo. Una composicion que se emplea para la inhibicion del crecimiento del pelo en un mamífero, la cual incluye un compuesto que es; (1) un inhibidor de la sintasa de la glucosilceramida; (2) un inhibidor de la ceramidasa: (3) ceramida; (4) un análogo de la ceramida; y/o (5) un inductor de la esfingomielinasa; en una cantidad efectiva para reducir el crecimiento del pelo, y un portador o vehículo no toxico, dermatologicamente aceptable. Una composicion preferida incluye por lo menos un compuesto que aumenta los niveles celulares de ceramida cuando se aplica topicamente, un vehículo cosmético y/o dermatologicamente aceptable. La composicion puede ser un solido, un semi-solido o un líquido. La composicion puede ser, por ejemplo, un producto cosmético y dermatologico, en forma de pomada, locion, espuma, crema, gel o una solucion hidroalcoholica, por ejemplo. La composicion también puede formularse como una preparacion para afeitarse o un producto para después de afeitar. El vehículo en sí puede ser inerte o puede poseer beneficios cosméticos, fisiologicos y/o farmacéuticos propios. Los ejemplos de los inhibidores de sintasa de la glucosilceramida son: 1-fenil-2-decanoilamino-3-morfolino-1-propanol (PDMP);1-fenil-2-hexadecanoilamino-3-morfolino-1-propanol (PPMP); 1-fenil-2-hexadecanoilamino-3-pirrolidino-1-propanol (PPPP); 1-fenil-2-palmitoilamino-3-pirrolidino-1-propanol (P4); D-treo-4'-hidroxi-PA; D-treo-3',4'-metilendioxifenil-P4; D-treo-trimetilendioxifenil-P4; D-treo-3',4'-etilendioxifenil-Pa; ''N-butildeoxinojirimicina (NBDN)''; y ''N-(5-adamantan)-1-il-metoxi)pentil)-deoxinorjirimicina''. Los ejemplos de los inhibidores de la ceramidasa incluyen los siguientes: D-eritro-2(N-miristoilamino)-1-fenil-1-propanol (D-eritro-MAPP); N-oleoil-etanolamina; y (1S,2R)-(+)-fenilpropanolamina. Los ejemplos de los análogos de la ceramida comprenden los siguientes: N-acetilesfingosina (C2-ceramida); N-hexanoilesfingosina (C6-Ceramida); N-octanoilesfingosina (C8-ceramida); N-octanoil-DL-eritro dihidroesfingosina; N-octil-D-eritro-esfingonsina; y N-tiocetilesfingosina; y 4-dodecanoilamino-decan-5-ol. La composicion puede incluir más de un compuesto que aumente los niveles celulares de ceramida. Por otro lado, la composicion puede comprender uno o más tipos diferentes de agentes que reducen el crecimiento del pelo. La concentracion del compuesto que aumenta los niveles celulares de ceramida en la composicion puede modificarse dentro de una escala amplia, hasta lograr una solucion saturada, con preferencia, desde 0,1% hasta 30% en peso o incluso, más; la reduccion del crecimiento del pelo aumenta a medida que se incrementa la cantidad de compuesto aplicado por unidad de superficie de la piel. La cantidad máxima efectivamente aplicada queda limitada solamente por la velocidad a la cual el compuesto penetra en la piel. Las cantidades efectivas pueden variar, por ejemplo, entre 10 y 3000 microgramos o más, por centímetro cuadrado de piel.
ARP010100242A 2000-01-25 2001-01-19 Reduccion del crecimiento del pelo AR028498A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/490,486 US6235737B1 (en) 2000-01-25 2000-01-25 Reduction of hair growth

Publications (1)

Publication Number Publication Date
AR028498A1 true AR028498A1 (es) 2003-05-14

Family

ID=23948266

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010100242A AR028498A1 (es) 2000-01-25 2001-01-19 Reduccion del crecimiento del pelo

Country Status (10)

Country Link
US (1) US6235737B1 (es)
EP (1) EP1250119B1 (es)
AR (1) AR028498A1 (es)
AT (1) ATE374643T1 (es)
AU (1) AU2001229712A1 (es)
CA (1) CA2385006C (es)
DE (1) DE60130735T2 (es)
ES (1) ES2290151T3 (es)
MX (1) MXPA02005091A (es)
WO (1) WO2001054654A2 (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3973748B2 (ja) 1998-01-14 2007-09-12 花王株式会社 発毛抑制剤
USRE43327E1 (en) 2001-01-08 2012-04-24 Aminex Therapeutics, Inc. Hydrophobic polyamine analogs and methods for their use
US7432302B2 (en) * 2001-01-08 2008-10-07 Mediquest Therapeutics, Inc. Composition containing polyamine transport inhibitor and use thereof
US7439271B2 (en) 2001-06-27 2008-10-21 The Gillette Company Reduction of hair growth
WO2003005965A2 (en) * 2001-07-11 2003-01-23 Musc Foundation For Research Development Modulators of ceramidase and methods of use based thereon
US6743822B2 (en) 2001-08-10 2004-06-01 The Gillette Company Reduction of hair growth
US7261878B2 (en) * 2001-08-10 2007-08-28 The Gillette Company Reduction of hair growth
US20030036561A1 (en) * 2001-08-10 2003-02-20 Peter Styczynski Reduction of hair growth
EP1287815A1 (en) * 2001-08-31 2003-03-05 Cosmoferm B.V. Use of a sphingoid base for inhibiting ceramidase activity
US6869519B2 (en) * 2001-09-27 2005-03-22 National Institute Of Advanced Industrial Science And Technology Electrolytic process for the production of metallic copper and apparatus therefor
US7160921B2 (en) * 2002-01-29 2007-01-09 The Gillette Company Reduction of hair growth
US20040198821A1 (en) * 2002-01-29 2004-10-07 Hwang Cheng Shine Reduction of hair growth
DE10214506A1 (de) * 2002-04-02 2003-10-16 Beiersdorf Ag Verwendung von Desoxynojirimycin und dessen Derivaten zur Behandlung und Prophylaxe degenerativer Hautzustände
US20030199584A1 (en) * 2002-04-11 2003-10-23 Ahluwalia Gurpreet S. Reduction of hair growth
US7585518B2 (en) * 2002-11-19 2009-09-08 Kimberly-Clark Worldwide, Inc. Products and methods for maintaining or increasing ceramide levels in skin
US7037535B2 (en) * 2002-11-19 2006-05-02 Kimberly-Clark Worldwide, Inc. Method and composition for neutralizing house dust mite feces
US20040141935A1 (en) * 2003-01-21 2004-07-22 Peter Styczynski Reduction of hair growth
US7015349B2 (en) * 2003-03-26 2006-03-21 The Gillette Company Reduction of hair growth
US20050019379A1 (en) * 2003-07-22 2005-01-27 Kimberly-Clark Worldwide, Inc. Wipe and methods for improving skin health
EP1680112B1 (en) * 2003-10-29 2010-12-15 Genzyme Corporation N-(5-adamantane-1-yl-methoxy-pentyl)deoxynojirimycin or a pharmaceutically salt thereof for use in the treatment of insulin resistance
EP1528056A1 (en) * 2003-10-29 2005-05-04 Academisch Ziekenhuis bij de Universiteit van Amsterdam Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
US20050112075A1 (en) * 2003-11-25 2005-05-26 Hwang Cheng S. Reduction of hair growth
WO2005067627A2 (en) 2004-01-07 2005-07-28 E-L Management Corporation Cosmetic composition and method for retarding hair growth
ES2343528T3 (es) * 2004-01-16 2010-08-03 Cognis France, S.A.S. Uso para el extracto de gymnema sylvestris.
US20050249685A1 (en) * 2004-04-27 2005-11-10 Natalia Botchkareva Reduction of hair growth
US20090111812A1 (en) * 2004-06-14 2009-04-30 Musc Foundation For Research Development Methods for treating inflammatory disorders
JP2008519840A (ja) * 2004-11-10 2008-06-12 ジェンザイム・コーポレイション 糖尿病の処置方法
AU2005319290A1 (en) * 2004-12-22 2006-06-29 The Gillette Company Reduction of hair growth
US20060134048A1 (en) * 2004-12-22 2006-06-22 Douglas Shander Reduction of hair growth
WO2006069192A1 (en) * 2004-12-22 2006-06-29 The Gillette Company Reduction of hair growth with survivin inhibitors
US7618956B2 (en) * 2005-05-31 2009-11-17 The Gillette Company Reduction of hair growth
US20070059264A1 (en) * 2005-09-13 2007-03-15 Ahluwalia Gurpreet S Reduction of hair growth
US7727516B2 (en) * 2006-02-28 2010-06-01 The Procter & Gamble Company Reduction of hair growth
ES2546181T3 (es) 2006-05-09 2015-09-21 Genzyme Corporation Métodos de tratar la enfermedad del hígado graso mediante inhibición de la síntesis de glucoesfingolípidos
EP2167485B1 (en) 2007-05-31 2015-09-30 Genzyme Corporation 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
MX2010003603A (es) 2007-10-05 2010-06-02 Genzyme Corp Metodo para el tratamiento de enfermedades de riñon poliquisticas con derivados de ceramida.
WO2009132082A2 (en) * 2008-04-22 2009-10-29 Medical College Of Georgia Research Institute, Inc. Immunogenic compositions containing ceramide and methods of use thereof
CA2731685A1 (en) 2008-07-28 2010-02-04 Genzyme Corporation Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease
MX2011003517A (es) 2008-10-03 2011-05-25 Genzyme Corp Inhibidores de la glucosilceramida sintasa tipo 2-acilaminopropanol.
MX2012009637A (es) * 2010-02-17 2012-09-12 Procter & Gamble Articulo depilatorio eficaz.
ES2379703T3 (es) * 2010-03-26 2012-04-30 The Procter And Gamble Company Método de depilación y kit para depilación
WO2011119557A2 (en) * 2010-03-26 2011-09-29 The Procter & Gamble Company Kit and method for removing hair
KR20150091983A (ko) * 2014-02-04 2015-08-12 (주)네오팜 발모촉진용 또는 탈모방지용 조성물
EP3785706B1 (en) 2016-03-25 2023-06-07 Aminex Therapeutics, Inc. Bioavailable polyamines
WO2019018185A1 (en) 2017-07-15 2019-01-24 Arisan Therapeutics Inc. ENANTIOMERICALLY PURE ADAMATANE DERIVATIVES FOR THE TREATMENT OF FILOVIRUS INFECTIONS
US20210244638A1 (en) * 2018-06-05 2021-08-12 Subroto B. Chatterjee Inhibitors of glycosphingolipid synthesis and methods of use
CA3193185A1 (en) 2020-09-30 2022-04-07 Mark R. Burns Combination drug substance of polyamine transport inhibitor and dfmo

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3426137A (en) * 1965-12-23 1969-02-04 Olin Mathieson Hair growth inhibiting by aminobenzophenones
US4161540A (en) * 1966-08-22 1979-07-17 Schering Corporation Antiandrogenic agents and methods for the treatment of androgen dependent disease states
GB1458349A (en) * 1972-12-05 1976-12-15 Sykora F Composition for and a process therewith of treating the hair and/or scalps of animals
US4039669A (en) * 1975-08-01 1977-08-02 Sterling Drug Inc. Composition for topical application and use thereof
US4139638A (en) * 1976-09-23 1979-02-13 Schering Corporation Methods for the treatment of hirsutism
FR2380775A1 (fr) * 1977-02-22 1978-09-15 Sederma Sarl Composition " apres-epilation " favorisant un ralentissement progressif de la repousse des poils
US4191775A (en) * 1977-12-15 1980-03-04 Imperial Chemical Industries Limited Amide derivatives
US4269831A (en) * 1979-05-09 1981-05-26 Sterling Drug Inc. Topical dermatological method of use of an androstenopyrazole
US4439432A (en) * 1982-03-22 1984-03-27 Peat Raymond F Treatment of progesterone deficiency and related conditions with a stable composition of progesterone and tocopherols
JP2519024B2 (ja) * 1982-06-07 1996-07-31 花王株式会社 毛髪化粧料
US4508714A (en) * 1983-11-14 1985-04-02 Tihomir Cecic Organic scalp lotion
US4885289A (en) * 1983-12-12 1989-12-05 Breuer Miklos M Alteration of character of male beard growth
US4720489A (en) * 1984-10-15 1988-01-19 Douglas Shander Hair growth modification with ornithine decarboxylase inhibitors
US4935231A (en) * 1985-08-28 1990-06-19 Repligen Corporation Use of thioredoxin, thioredoxin-derived, or thioredoxin-like dithiol peptides in hair care preparations
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
DE3871974T2 (de) * 1987-02-12 1993-01-14 Estee Lauder Inc Haarschutzmittel und verfahren.
GB9009793D0 (en) * 1990-05-01 1990-06-20 Unilever Plc Cosmetic composition
US5096911A (en) 1990-06-25 1992-03-17 Ahluwalia Gurpreet S Alteration of rate and character of hair growth
EP0543949B1 (en) 1990-08-14 1997-10-22 HANDELMAN, Joseph H. Enzymic alteration of hair growth
US5189212A (en) 1990-09-07 1993-02-23 University Of Georgia Research Foundation, Inc. Triarylethylene carboxylic acids with estrogenic activity
US5095007A (en) 1990-10-24 1992-03-10 Ahluwalia Gurpreet S Alteration of rate and character of hair growth
DE4038693A1 (de) 1990-12-05 1992-06-11 Heverhagen Ulrich Mittel zum reduzieren des wachstums bzw. zum entfernen der haare am menschlichen koerper
US5143925A (en) 1990-12-20 1992-09-01 Douglas Shander Alteration of rate and character of hair growth
GB9118866D0 (en) * 1991-09-04 1991-10-23 Unilever Plc Cosmetic composition
GB9118979D0 (en) 1991-09-04 1991-10-23 Unilever Plc Cosmetic composition
US5328686A (en) 1991-10-30 1994-07-12 Douglas Shander Treatment of acne or of pseudofolliculitis barbae
ES2173874T3 (es) 1991-11-05 2002-11-01 Gillette Co Alteracion de la velocidad y caracter del crecimiento del pelo.
US5364885A (en) 1992-11-13 1994-11-15 Ahluwalia Gurpreet S Reduction of hair growth
US5411991A (en) 1992-12-22 1995-05-02 Shander; Douglas Method of reducing hair growth employing sulfhydryl active compounds
US5648394A (en) 1993-05-27 1997-07-15 Boxall; Brian Alfred Topical composition for inhibiting hair growth
US5362748A (en) 1993-09-15 1994-11-08 The Procter & Gamble Company Methods of using diethyldithiocarbamic acid for the prevention of hair growth
WO1995016665A1 (en) * 1993-12-17 1995-06-22 Unilever Plc Synthetic ceramides and their use in cosmetic compositions
US5474763A (en) 1994-03-11 1995-12-12 Shander; Douglas Reduction of hair growth
US5455234A (en) 1994-03-16 1995-10-03 Ahluwalia; Gurpreet S. Inhibition of hair growth
US5468476A (en) 1994-03-16 1995-11-21 Ahluwalia; Gurpreet S. Reduction of hair growth
FR2718961B1 (fr) * 1994-04-22 1996-06-21 Oreal Compositions pour le lavage et le traitement des cheveux et de la peau à base de céramide et de polymères à groupements cationiques.
FR2719216B1 (fr) * 1994-05-02 1996-05-31 Oreal Composition pour le traitement et la protection des cheveux à base de céramides et de polymères de Vinylpyrrolidone.
US5554608A (en) 1994-09-28 1996-09-10 Ahluwalia; Gurpreet S. Inhibition of hair growth
US5674477A (en) 1995-02-28 1997-10-07 Ahluwalia; Gurpreet S. Reduction of hair growth
US5645825A (en) 1995-06-07 1997-07-08 The Procter & Gamble Company Depilatory compositions comprising sulfhydryl compounds
DE19523479C1 (de) * 1995-06-28 1996-10-10 Henkel Kgaa Verwendung von Zuckermonosäureamiden in kosmetischen Präparaten
US5728736A (en) 1995-11-29 1998-03-17 Shander; Douglas Reduction of hair growth
US5652273A (en) 1995-11-30 1997-07-29 Henry; James Reduction of hair growth
JP2000515511A (ja) * 1996-07-12 2000-11-21 ジヨンソン・アンド・ジヨンソン・コンシユーマー・カンパニーズ・インコーポレーテツド 毛包乳頭のアポトーシスによる毛の成長および毛の色素沈着を変える方法ならびにそのための組成物
US5908867A (en) 1996-07-18 1999-06-01 Henry; James P. Reduction of hair growth
US5840752A (en) 1996-11-21 1998-11-24 Henry; James P. Reduction of hair growth
ZA9711121B (en) 1996-12-13 1998-06-23 Handelman Joseph H Reduction of hair growth.
US6037326A (en) 1996-12-31 2000-03-14 Styczynski; Peter Reduction of hair growth
US5939458A (en) 1997-09-22 1999-08-17 Henry; James P. Reduction of hair growth
US5958946A (en) 1998-01-20 1999-09-28 Styczynski; Peter Modulation of hair growth
US6020006A (en) 1998-10-27 2000-02-01 The Gillette Company Reduction of hair growth
EP1090625B1 (en) * 1999-10-05 2004-12-22 Kao Corporation Topical composition for the skin and use thereof

Also Published As

Publication number Publication date
DE60130735D1 (de) 2007-11-15
ATE374643T1 (de) 2007-10-15
WO2001054654A2 (en) 2001-08-02
ES2290151T3 (es) 2008-02-16
CA2385006A1 (en) 2001-08-02
WO2001054654A3 (en) 2002-02-21
AU2001229712A1 (en) 2001-08-07
CA2385006C (en) 2006-09-12
DE60130735T2 (de) 2008-07-17
EP1250119B1 (en) 2007-10-03
MXPA02005091A (es) 2002-11-07
US6235737B1 (en) 2001-05-22
EP1250119A2 (en) 2002-10-23

Similar Documents

Publication Publication Date Title
AR028498A1 (es) Reduccion del crecimiento del pelo
JP3768233B2 (ja) 毛髪成長の抑制
AU776167B2 (en) Reduction of hair growth
KR20140060475A (ko) 항여드름제를 함유하는 조성물 및 이의 용도
JP2008542251A (ja) レスベラトロルを含む組成物及び人間の発毛の低減のためのその局所的使用
WO2005016329A1 (en) Topical compositions of urea and ammonium lactate
JPH02180827A (ja) ニコチン酸のトコフェロール、ベンジル、キサンチノールもしくはヘキシルエステルまたはトコフェロール酢酸エステルの用途
ES2313124T3 (es) Reduccion del crecimiento capilar aplicando un agonista del receptor de prostagladina.
ATE390924T1 (de) Stabile creme-zubereitungen von phenyl- pyridonverbindungen für topische anwendung
EP4054575A1 (en) Novel method
JP3981074B2 (ja) オルニチンデカルボキシラーゼインヒビターの毛包輸送のための局所用組成物
CA2043673A1 (fr) Procede de teinture des fibres keratiniques avec le 2,4-diamino 1,3-dimethoxybenzene a ph acide et compositions mises en oeuvre
US6884772B1 (en) Depilatories and agents for external use
ES2342655T3 (es) Reduccion del crecimiento del pelo.
RU2291691C2 (ru) Уменьшение роста волос
EP0477927A1 (en) Sebaceous excitosecretory agent
ES2350583T3 (es) Composición que comprende wortmanina y uso tópico de la misma para reducir el crecimiento del vello humano.
JPS63243016A (ja) 養毛化粧料
AU2013301601B2 (en) Eprotirome for use in the prevention and/or treatment of hair disorders and compositions thereof
RU2305540C2 (ru) Уменьшение роста волос
WO2016102969A1 (en) Inhibition of hair growth
US20220040077A1 (en) Use of evodone or a derivative thereof as a cooling agent
WO2020161255A1 (en) Novel method for reducing hair growth
JPS63255213A (ja) 養毛化粧料
JP2024010518A (ja) 皮膚外用剤

Legal Events

Date Code Title Description
FA Abandonment or withdrawal